Published mark

Mirum Pharmaceuticals, Inc.

NASDAQ: MIRM. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:5bf954d5-c3c5-4acc-a62b-862560d83e78
SEC CIK
0001759425
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 12, 2026
Newest evidence
May 3, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Christopher PeetzChief Executive Officer
Chair
Michael Grey
Independent
Not published5 directors published
Published claims
313 distinct sources
Evidence records
60 pinned
Source conflicts
0None open

Built from 3 distinct sources and 6 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Joanne Quan executive of Mirum Pharmaceuticals, Inc., effective 2026-04-23.

EffectiveEffective Apr 23, 2026E4

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Named Executive Officer, M.D.Joanne QuanApr 2026currentSource reportedE4
Chief Executive OfficerChristopher PeetzNot capturedunknownSource reportedE2
Chief Financial OfficerEric BjerkholtNot capturedunknownSource reportedE2
Chief Medical OfficerJoanne Quan, M.D.Not capturedunknownSource reportedE2
Named Executive OfficerLaura BregeNot capturedunknownSource reportedE5
President and Chief Operating OfficerPeter RadovichNot capturedunknownSource reportedE2

Board of directors

Evidence

5 directors published. Independence determinations are not published for every director.

DirectorStatusSinceCommitteesClaim
Laura BregeIndependence not published2019Audit Committee, chairNominating and Corporate Governance CommitteeSource reportedE3
Laurent FischerIndependence not published2019Compensation Committee, chairSource reportedE3
Patrick HeronIndependence not published2018Compensation CommitteeSource reportedE3
Timothy WalbertIndependence not published2023Nominating and Corporate Governance Committee, chairSource reportedE3
William FaireyIndependence not published2021Audit CommitteeCompensation CommitteeSource reportedE3
Christopher PeetzNot independentNot publishedNone publishedSource reportedE2
Laurent Fischer, M.D.IndependentNot publishedNone publishedSource reportedE2
Lon Cardon, Ph.D., FMedSciIndependentNot publishedNone publishedSource reportedE2
Michael GreyIndependentChairNot publishedNone publishedSource reportedE2
Saira Ramasastry, M.S., M.Phil.IndependentNot publishedNone publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
Audit CommitteeLaura BregeLaura Brege, William FaireyNot described in the published record
Compensation CommitteeLaurent FischerLaurent Fischer, Patrick Heron, William FaireyNot described in the published record
Nominating and Corporate Governance CommitteeTimothy WalbertTimothy Walbert, Laura BregeNot described in the published record
Committee RecordAudit Committee: Chair Laura Brege; Members Laura Brege (Chair); William Fairey
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_record:22
Committee AppointmentLaura Brege: chair, Audit Committee
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_appointment:23
Committee AppointmentWilliam Fairey: member, Audit Committee
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_appointment:24
Committee RecordCompensation Committee: Chair Laurent Fischer; Members Laurent Fischer (Chair); Patrick Heron; William Fairey
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_record:25
Committee AppointmentLaurent Fischer: chair, Compensation Committee
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_appointment:26
Committee AppointmentPatrick Heron: member, Compensation Committee
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_appointment:27
Committee AppointmentWilliam Fairey: member, Compensation Committee
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_appointment:28
Committee RecordNominating and Corporate Governance Committee: Chair Timothy Walbert; Members Timothy Walbert (Chair); Laura Brege
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_record:29
Committee AppointmentTimothy Walbert: chair, Nominating and Corporate Governance Committee
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_appointment:30
Committee AppointmentLaura Brege: member, Nominating and Corporate Governance Committee
Source reportedE6
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:committee_appointment:31

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerChristopher Peetz, Chief Executive Officer
Source reportedE2
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:leadership_role:16
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingMIRM (NASDAQ)
Source reportedE1
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:security_listing:32
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 12, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameMirum Pharmaceuticals, Inc.
Source reportedE1
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:entity_status:3
Published FactHealthcare
Source reportedE1
company:5bf954d5-c3c5-4acc-a62b-862560d83e78:published_fact:5

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
6 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 12, 2026. Cited by 5 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    SEC DEF 14A 0001759425-26-000027
    sec def 14a. Published Apr 23, 2026. Retrieved Sep 6, 2026. Cited by 9 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    DEF 14A mirm-20260423.htm
    sec proxy. Published Apr 23, 2026. Retrieved Sep 2, 2026. Cited by 5 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    MIRM DEF 14A executive officers
    sec filing. Published Apr 23, 2026. Retrieved May 15, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    MIRM executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    Audit Committee
    governance_people_committees. sec proxy. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 12, 2026
  • Joanne Quan executive of Mirum Pharmaceuticals, Inc., effective 2026-04-23.
  • Timothy Walbert seat on Mirum Pharmaceuticals, Inc., effective 2023-01-01.
  • William Fairey seat on Mirum Pharmaceuticals, Inc., effective 2021-01-01.
  • Laura Brege seat on Mirum Pharmaceuticals, Inc., effective 2019-01-01.
  • Laurent Fischer seat on Mirum Pharmaceuticals, Inc., effective 2019-01-01.
  • Patrick Heron seat on Mirum Pharmaceuticals, Inc., effective 2018-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:5bf954d5-c3c5-4acc-a62b-862560d83e78, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/mirum-pharmaceuticals-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership6
  4. Board10
  5. Committees3
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims4
  15. Coverage gaps17
  16. Linked people14
  17. Subject and corrections6
  18. Evidence6
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:5bf954d5-c3c5-4acc-a62b-862560d83e78
  • Cite this recordMirum Pharmaceuticals, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/mirum-pharmaceuticals-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Mirum Pharmaceuticals, Inc.Company
  • Joanne QuanPerson
  • Christopher PeetzPerson
  • Eric BjerkholtPerson
  • Joanne Quan, M.D.Person
  • Laura BregePerson
  • Peter RadovichPerson
  • Laurent FischerPerson
  • Patrick HeronPerson
  • Timothy WalbertPerson
  • William FaireyPerson
  • Laurent Fischer, M.D.Person
  • Lon Cardon, Ph.D., FMedSciPerson
  • Michael GreyPerson
  • Saira Ramasastry, M.S., M.Phil.Person
  • Sections
    OverviewMirum Pharmaceuticals, Inc.
  • MonitoringMirum Pharmaceuticals, Inc.
  • LeadershipMirum Pharmaceuticals, Inc.
  • BoardMirum Pharmaceuticals, Inc.
  • CommitteesMirum Pharmaceuticals, Inc.
  • Control and votingMirum Pharmaceuticals, Inc.
  • Authority to actMirum Pharmaceuticals, Inc.
  • FinancialsMirum Pharmaceuticals, Inc.
  • GovernanceMirum Pharmaceuticals, Inc.
  • RiskMirum Pharmaceuticals, Inc.
  • AI oversightMirum Pharmaceuticals, Inc.
  • LegalMirum Pharmaceuticals, Inc.
  • CompensationMirum Pharmaceuticals, Inc.
  • Other published claimsMirum Pharmaceuticals, Inc.
  • Coverage gapsMirum Pharmaceuticals, Inc.
  • Linked peopleMirum Pharmaceuticals, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.